Himension Capital (Singapore) Pte. Ltd. Crispr Therapeutics Ag Transaction History
Himension Capital (Singapore) Pte. Ltd.
- $1.28 Billion
- Q3 2024
A detailed history of Himension Capital (Singapore) Pte. Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Himension Capital (Singapore) Pte. Ltd. holds 81,145 shares of CRSP stock, worth $3.52 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
81,145
Previous 77,542
4.65%
Holding current value
$3.52 Million
Previous $4.19 Million
8.95%
% of portfolio
0.3%
Previous 0.3%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
486Shares Held
57.9MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$344 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$326 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$130 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$129 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$129 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.39B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....